Global Oxygen Scavengers Market Report 2022 to 2031: Rising Demand for Convenience Foods and Active Food Packaging is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Oxygen Scavengers Market – A Global and Regional Analysis: Focus on Type, Form, End User, and Region – Analysis and Forecast, 2022-2031” report has been added to ResearchAndMarkets.com’s offering. The global oxygen scavengers market is projected to reach $4,318.4 million by 2031 from $2,324.4 million in 2021, growing at a CAGR of 6.4% … [Read more…]

NextGen Healthcare Prices Upsized $230.0 Million Convertible Senior Notes Offering

REMOTE-FIRST COMPANY/NEW YORK–(BUSINESS WIRE)–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced the pricing of its offering of $230,000,000 aggregate principal amount of 3.75% convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of … [Read more…]

Insights on the Prosthetic Heart Valve Global Market to 2031 – Increasing Number of Heart Surgeries Conducted is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Prosthetic Heart Valve Market By Product: Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering. The global prosthetic heart valves market was valued at $ 6,889.3 million in 2021 and is projected to reach $ 19,738.23 million by 2031, registering a CAGR of 11.1% from 2022 to 2031. … [Read more…]

Confo Therapeutics’ Scientific Founder Jan Steyaert Receives Prestigious Gabbay Award for Contributions to Structural Biology

GHENT, Belgium–(BUSINESS WIRE)–Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today announced that its Scientific Founder and Scientific Advisory Board Chairman, Professor Jan Steyaert, PhD, has been selected as the recipient of the Jacob and Louise Gabbay Award. Each year the award, administered by Boston-based Brandeis University, is given … [Read more…]

SINOVAC to Showcase Products at CPHI Frankfurt

BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company will participate in CPHI Frankfurt, one of the world’s largest pharmaceutical exhibitions, from 1st to 3rd of November, in Frankfurt, Germany. At Booth#41G20, the first floor of Hall 4, Messe Frankfurt, SINOVAC will … [Read more…]

$32.2 Billion Global Interventional Cardiology Devices Market Report to 2027: Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Interventional Cardiology Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global interventional cardiology devices market reached a value of US$ 19.58 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 32.21 Billion by 2027, … [Read more…]

$7.8 Billion Worldwide Gene Expression Analysis Industry to 2027 – Featuring Agilent Technologies, GE Healthcare and Illumina Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Gene Expression Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global gene expression analysis market size reached US$ 4.2 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 7.8 Billion by 2027, exhibiting a CAGR of 10.87% … [Read more…]

Octave Presents Data from 13 Abstracts at ECTRIMS Forum 2022 Following Commercial Launch of Precision Care Solution for Multiple Sclerosis

Data demonstrates impact of Precision Care Solution to track MS disease activity at individual patient and population levels, provide quantitative and deeper insights, and potentially guide treatment decisions Poster supporting prior validation studies and providing results on expansion of the utility of the Octave MSDA test nominated as one of the top five posters at … [Read more…]

AI Drug Discovery Company Elix Commences Joint Research With Proprietary Screening Technology Holder SEEDSUPPLY

TOKYO–(BUSINESS WIRE)–Elix, Inc. (CEO: Shinya Yuki / HQ: Tokyo, hereinafter “Elix”) and SEEDSUPPLY Inc. (CEO: Naoki Tarui / HQ: Kanagawa, hereinafter “SEEDSUPPLY”) hereby announce the start of joint research. SEEDSUPPLY (https: //www.seedsupply.co.jp/) proposes an agile drug discovery process for small molecules that uses binder selection technology as a proprietary compound screening method. This technology can … [Read more…]

SYNLAB and Microba reinforce their combined expertise and expand strategic agreement on advanced gut microbiome test myBIOME

Launched in Spain and Colombia in 2020, myBIOME is an innovative gut microbiome examination based on technology developed by Microba’s leading researchers in the field of microbiome analysis. The combination of leading-edge comprehensive metagenomic sequencing and evidence- based reporting provides precise imaging of the gut microbiome. myBIOME provides a comprehensive analysis of the composition of … [Read more…]